OA patients were more likely to initiate duloxetine treatment at sub-therapeutic ( < 40 mg/day) dosing levels than CLBP patients (32.1% vs. 26.8%; p < 0.001). Results for 2011 were little change d from 2010 results. Conclusions Overall, patient profiles among duloxetine initiators with C...
Methods Alternatives to compare were: (1) duloxetine 60 mg / day and 120 mg / day and (2) pregabalin 300 mg / day and 450 mg / day. A decision tree model was developed with a 12 weeks time horizon in which patients maintained response, lost response or dropped out. Relative rates ...